Voya Financial Advisors, Inc. - ZOMEDICA PHARMACEUTICALS COR ownership

Quarter-by-quarter ownership
Voya Financial Advisors, Inc. ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$1,000
-66.7%
10,0000.0%0.00%
Q2 2020$3,000
+50.0%
10,0000.0%0.00%
Q1 2020$2,000
-33.3%
10,0000.0%0.00%
Q4 2019$3,000
-25.0%
10,0000.0%0.00%
Q3 2019$4,000
+100.0%
10,0000.0%0.00%
Q2 2019$2,000
-33.3%
10,0000.0%0.00%
Q1 2019$3,000
-76.9%
10,0000.0%0.00%
-100.0%
Q4 2018$13,00010,0000.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q3 2023
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,079,080$27,178,0000.29%
jvl associates llc 58,500$132,0000.13%
Sigma Planning Corp 27,500$62,0000.00%
NORTHWEST WEALTH MANAGEMENT, LLC 280$1,0000.00%
Tower Research Capital LLC (TRC) 4,158$9,0000.00%
Ameritas Investment Partners, Inc. 2,890$7,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 60,388$136,0000.00%
UBS Group AG 9,495$21,0000.00%
RHUMBLINE ADVISERS 31,685$71,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1,290$2,902,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders